ADVANCED SQUAMOUS NON SMALL CELL LUNG CANCER
Clinical trials for ADVANCED SQUAMOUS NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SQUAMOUS NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED SQUAMOUS NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a gentler chemo combo with delayed immunotherapy tame advanced lung cancer?
Disease control Recruiting nowThis study investigates whether a lower dose of two chemotherapy drugs (carboplatin and nab-paclitaxel) combined with a delayed dose of the immunotherapy serplulimab can effectively treat advanced squamous non-small cell lung cancer. The trial compares this gentler regimen to a s…
Matched conditions: ADVANCED SQUAMOUS NON SMALL CELL LUNG CANCER
Phase: EARLY_PHASE1 • Sponsor: People's Hospital of Quzhou • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug HDM2020 targets tough lung cancer in early trial
Disease control Recruiting nowThis early-phase trial is testing a new drug called HDM2020 in 150 people with advanced squamous non-small cell lung cancer. The drug is designed to target a protein on cancer cells and deliver a chemotherapy agent directly to them. The main goals are to check if the drug is safe…
Matched conditions: ADVANCED SQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for lung cancer: experimental drug RC148 takes on standard therapy
Disease control Recruiting nowThis study compares two treatments for people with advanced squamous non-small cell lung cancer who have not had prior therapy. Participants will receive either the experimental drug RC148 or the approved drug tislelizumab, both combined with chemotherapy. The goal is to see whic…
Matched conditions: ADVANCED SQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New study digs into long-term survival data for advanced lung cancer patients on immunotherapy
Knowledge-focused Recruiting nowThis study looks back at patients with advanced squamous non-small cell lung cancer who received tislelizumab combined with chemotherapy in a previous trial. Researchers want to see how long patients lived and find out who benefits most from this treatment. The goal is to better …
Matched conditions: ADVANCED SQUAMOUS NON SMALL CELL LUNG CANCER
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC